Mission Bay Capital backs Circle Pharma

San Francisco-based early-stage biotech firm Circle Pharma said Monday that it has secured an undisclosed amount of seed funding. The investors were Pfizer and QB3’s seed-stage venture fund Mission Bay Capital.

22 September 2014•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail